Equitable Holdings, Inc., together with its consolidated subsidiaries, operates as a diversified financial services company worldwide. The company operates through four segments: Individual Retirement, Group Retirement, Investment Management and Research, and Protection Solutions. The Individual Retirement segment offers a suite of variable annuity products primarily to affluent and high net worth individuals. The Group Retirement segment provides tax-deferred investment and retirement services or products to plans sponsored by educational entities, municipalities, and not-for-profit entities, as well as small and medium-sized businesses. The Investment Management and Research segment offers diversified investment management, research, and related solutions to various clients through institutional, retail, and private wealth management channels; and distributes its institutional research products and solutions. The Protection Solutions segment provides various variable universal life, indexed universal life, and term life products to help affluent and high net worth individuals, as well as small and medium-sized business owners; and a suite of life, short- and long-term disability, dental, and vision insurance products to small and medium-size businesses. The company was formerly known as AXA Equitable Holdings, Inc. and changed its name to Equitable Holdings, Inc. in January 2020. Equitable Holdings, Inc. was founded in 1859 and is based in New York, New York.

Equitable Holdings, Inc.

AGON Biotechnology provides practical solutions to various sectors with patented biosensor designs. The company develops bacteria sensors, screen printed electrodes, microbial air samplers, hypochlorous environment fogging devices, and electronic card components.

AGON Biotechnology

Equitable Holdings provides financial services and helps clients prepare for their financial future, self-described since 1859.

Metric
Company Name	Equitable Holdings, Inc.	AGON Biotechnology
Symbol	EQH
MSH ID	COM:EQUITABLEHOLDINGS	COM:AGONBIOTECHNOLOGY
Market	STOCKS	PRIVATE
Sector	Financial Services	Healthcare & Health Services
Industry	Insurance - Diversified	Biotechnology
Country	US	TR
Stage		Pre Seed
Employee Count	12.80K
Website	equitableholdings.com	agonbiotechnology.com
LinkedIn		agon-biyosens%C3%B6r
Founders

Metric
Market Cap	13.54B
Enterprise Value
Monthly Web Traffic	4.34K
Web Traffic Growth	-0.24
Valuation
Raised Capital

Metric
Revenue	10.53B
Revenue (LTM)
Revenue (NTM)
Gross Profit	6.30B
EBITDA	2.21B
Operating Income	2.21B
Net Income	1.30B
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.61
Operating Profit Margin	0.15
EBITDA Margin	0.21
Net Profit Margin	0.13
Return on Equity	0.57
Return on Assets	0.01
Return on Capital Employed	0.01

COM:EQUITABLEHOLDINGS

Equitable Holdings

Last Close

46.80

22/11 21:00

Market Cap

13.54B

Beta: -

Volume Today

2.19M

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	5.08
P/B Ratio	6.89
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	1.35
EV Multiple	108.37

Metric
Days Sales Outstanding	442.10
Days Payables Outstanding	425.61
Days Inventory Outstanding
Operating Cycle	172.29
Cash Conversion Cycle
Asset Turnover	0.04

Metric
Operating Cash Flow	-863M
Free Cash Flow	-980M
Cash Flow to Debt	0.16
Operating Cash Flow/Sales	0.05
Free Cash Flow Yield	-0.01

Metric
Cash & Equivalents	9.11B
Accounts Receivable	-1.47B
Inventory	-87.51B
Goodwill
Debt to Capitalization	0.73
Debt to Assets	0.02
Current Ratio	1.67
Quick Ratio	25.48

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.02
R&D to Revenue
SG&A to Revenue	0.22